Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13 II sensitizes Jurkat T cells to Ras-mediated apoptosis

Journal of Virology

Volumn 79, Issue 15, 2005, Pages 9449-9457

  Hiraragi, Hajime ^a   Michael, Bindhu ^a,d   Nair, Amrithraj ^a,d   Silic Benussi, Micol ^c   Ciminale, Vincenzo ^c   Lairmore, Michael ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; FAS LIGAND; GENE PRODUCT; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN P13; RAS PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EXPRESSION VECTOR; GENE MUTATION; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RABBIT; RETROVIRUS; T CELL LEUKEMIA; VIRUS MORPHOLOGY;

APOPTOSIS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; MITOCHONDRIA; PROVIRUSES; RAS PROTEINS; RETROVIRIDAE PROTEINS;

ANIMALIA; HUMAN T LYMPHOTROPIC VIRUS TYPE 1; HUMAN T-LYMPHOTROPIC VIRUS 1; ORYCTOLAGUS CUNICULUS;

EID: 22544437317     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.15.9449-9457.2005     Document Type: Article

References (40)

1. Albrecht, B., and M. D. Lairmore. 2002. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol. Mol. Biol. Rev. 66:396-406.
2. Bartoe, J. T., B. Albrecht, N. D. Collins, M. D. Robek, L. Ratner, P. L. Green, and M. D. Lairmore. 2000. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 74:1094-1100.
3. Ciminale, V., D. D'Agostino, L. Zotti, G. Franchini, B. K. Felber, and L. Chieco-Bianchi. 1995. Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology 209:445-456.
4. Ciminale, V., G. N. Pavlakis, D. Derse, C. P. Cunningham, and B. K. Felber, 1992. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J. Virol. 66:1737-1745.
5. Ciminale, V., L. Zotti, D. M. Dagostino, T. Ferro, L. Casareto, G. Franchini, P. Bernardi, and L. Chiecobianchi. 1999. Mitochondrial targeting of the p13(II) protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene 18:4505-4514.
6. Cox, A. D., and C. J. Der. 2003. The dark side of Ras: regulation of apoptosis. Oncogene 22:8999-9006.
7. Crul, M., G. J. de Klerk, J. H. Beijnen, and J. H. Schellens. 2001. Ras biochemistry and farnesyl transferase inhibitors: a literature survey. Anticancer Drugs 12:163-184.
8. D'Agostino, D. M., L. Ranzato, G. Arrigoni, I. Cavallari, F. Belleudi, M. R. Torrisi, M. Silic-Benussi, T. Ferro, V. Petronilli, O. Marin, L. Chieco-Bianchi, P. Bernardi, and V. Ciminale. 2002. Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J. Biol. Chem. 277:34424-34433.
9. D'Agostino, D. M., L. Zotti, T. Ferro, I. Cavallori, M. Silic-Benussi, L. Chieco-Bianchi, and V. Ciminale. 2001. Expression and functional properties of proteins encoded in the x-II ORF of HTLV-I. Virus Res. 78:35-43.
10. D'Agostino, D. M., L. Zotti, T. Ferro, G. Franchini, L. Chieco-Bianchi, and V. Ciminale. 2000. The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses. AIDS Res. Hum. Retrovir. 16:1765-1770.
11. D'Agostino, D. M., V. Ciminale, L. Zotti, A. Rosato, and L. Chiecobianchi. 1997. The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. J. Virol. 71:75-83.
12. Dahmoush, L., Y. Hijazi, E. Barnes, M. Stetler-Stevenson, and A. Abati. 2002. Adult T-cell leukemia/lymphoma: a cytopathologic, immunocytochemical, and flow cytometric study. Cancer 96:110-116.
13. Denis, G. V., Q. Yu, P. Ma, L. Deeds, D. V. Faller, and C. Y. Chen. 2003. Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras. J. Biol. Chem. 278:5775-5785.
14. Derse, D., J. Mikovits, and F. Ruscetti. 1997. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 237:123-128.
15. Ding, W., S. J. Kim, A. M. Nair, B. Michael, K. Boris-Lawrie, A. Tripp, G. Feuer, and M. D. Lairmore. 2003. Human T-cell lymphotropic virus type 1 p12(I) enhances interleukin-2 production during T-cell activation. J. Virol. 77:11027-11039.
16. Franchini, G., C. Nicot, and J. M. Johnson. 2003. Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv. Cancer Res. 89:69-132.
17. Gessain, A., R. Mahieux, and T. G. De. 1996. Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S132-S145.
18. Gulbins, E., R. Bissonnette, A. Mahboubi, S. Martin, W. Nishioka, T. Brunner, G. Baier, G. Baier-Bitterlich, C. Byrd, and F. Lang. 1995. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2:341-351.
19. Haimovitz-Friedman, A., R. N. Kolesnick, and Z. Fuks. 1997. Ceramide signaling in apoptosis. Br. Med. Bull. 53:539-553.
20. Johnston, S. R. 2001. Farnesyl transferase inhibitors: a novel targeted therapy for cancer. Lancet Oncol. 2:18-26.
21. Kerkhofs, P., H. Heremans, A. Burny, R. Kettmann, and L. Willems. 1998. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J. Virol. 72:2554-2559.
22. Kimata, J. T., F. Wong, J. Wang, and L. Ratner. 1994. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 204:656-664.
23. Koralnik, I. J., J. Fullen, and G. Franchini. 1993. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 67:2360-2366.
24. Lefebvre, L., V. Ciminale, A. Vanderplasschen, D. D'Agostino, A. Burny, L. Willems, and R. Kettmann. 2002. Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J. Virol. 76:7843-7854.
25. Lefebvre, L., A. Vanderplasschen, V. Ciminale, H. Heremans, O. Dangoisse, J. C. Jauniaux, J. F. Toussaint, V. Zelnik, A. Burny, R. Kettmann, and L. Willems. 2002. Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J. Virol. 76:1400-1414.
26. Mayo, M. W., J. L. Norris, and A. S. Baldwin. 2001. Ras regulation of NF-kappa B and apoptosis. Methods Enzymol. 333:73-87.
27. Michael, B., A. Nair, and M. D. Lairmore. 2004. Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front. Biosci. 9:2556-2576.
28. Mortreux, F., A. S. Gabet, and E. Wattel. 2003. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 17:26-38.
29. Mulloy, J. C., R. W. Crownley, J. Fullen, W. J. Leonard, and G. Franchini. 1996. The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface. J. Virol. 70:3599-3605.
30. Nicot, C., M. Dundr, J. M. Johnson, J. R. Fullen, N. Alonzo, R. Fukumoto, G. L. Princler, D. Derse, T. Misteli, and G. Franchini. 2004. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat. Med. 10:197-201.
31. Pique, C., A. Uretavidal, A. Gessain, B. Chancerel, O. Gout, R. Tamouza, F. Agis, and M. C. Dokhelar. 2000. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 191:567-572.
32. Robek, M. D., and L. Ratner. 2000. Immortalization of T lymphocytes by human T-cell leukemia virus type 1 is independent of the tax-CBP/p300 interaction. J. Virol. 74:11988-11992.
33. Robek, M. D., F. H. Wong, and L. Ratner. 1998. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J. Virol. 72:4458-4462.
34. Ruvolo, P. P. 2001. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia 15:1153-1160.
35. Shi, Y., J. Gera, J. H. Hsu, B. Van Ness, and A. Lichtenstein. 2003. Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells. Mol. Cancer Ther. 2:563-572.
36. Silic-Benussi, M., I. Cavallari, T. Zorzan, E. Rossi, H. Hiraragi, A. Rosato, K. Horie, D. Saggioro, M. D. Lairmore, L. Willems, L. Chieco-Bianchi, D. M. D'Agostino, and V. Ciminale. 2004. Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc. Natl. Acad. Sci. USA 101:6629-6634.
37. Silverman, L. R., A. J. Phipps, A. Montgomery, L. Ratner, and M. D. Lairmore. 2004. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J. Virol. 78:3837-3845.
38. Takada, Y., F. R. Khuri, and B. B. Aggarwal. 2004. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis. J. Biol. Chem. 279:26287-26299.
39. Wrzesinski, S., R. Seguin, Y. Liu, S. Domville, V. Planelles, P. Massa, E. Barker, J. Antel, and G. Feuer. 2000. HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. AIDS Res. Hum. Retrovir. 16:1771-1776.
40. Younis, I., L. Khair, M. Dundr, M. D. Lairmore, G. Franchini, and P. L. Green. 2004. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J. Virol. 78:11077-11083.